Healthcare

Techseriesinsight > Blog > News > Healthcare

November 5, 2025
PRNewswire
Healthcare, News

CRUNCH FITNESS FRANCHISEE CELEBRATES MILESTONE 10-YEAR ANNIVERSARY OF CRUNCH BRADENTON

CR Fitness Holdings, the leading and fastest growing franchise group of Crunch Fitness, announced today the milestone anniversary of Crunch Bradenton, a 28,400-square-foot fitness facility located at 4836 14th...

October 16, 2025
Business Wire
Healthcare, News

Zelis Study Shows Employers & Consumers Believe Price Transparency, Digital Tools and AI Will Improve Healthcare

Zelis, a leading provider of healthcare technology solutions, today released a comprehensive industry study, The State of the Healthcare Financial Experience, revealing what factors employers and consumers believe will improve...

October 13, 2025
Business Wire
Healthcare, News

Alleviate Health, Backed by Andreessen Horowitz, Launches to Accelerate Patient Recruitment at Scale

Alleviate Health, the AI recruiter to accelerate patient recruitment for clinical research sites, today publicly launched their product and announced their $4.3M seed round led by Andreessen Horowitz. Alleviate...

September 18, 2025
PRNewswire
Biotechnology, Healthcare, News

Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine

Illumina, Inc. (NASDAQ: ILMN), and Nashville Biosciences, LLC (NashBio), today announced Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) (Alnylam) as a member of the Alliance for Genomic Discovery (AGD). Alnylam, a pioneer in RNA interference (RNAi)...

September 17, 2025
PRNewswire
Biotechnology, Healthcare, News

Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms

Lindus Health, the “anti-CRO” running radically faster, more reliable clinical trials for life science pioneers, and Berlin-based femtech startup Frieda Health have announced the successful completion of their clinical trial for a...

September 15, 2025
Business Wire
Biotechnology, Healthcare, News

Atom Therapeutics Enrolls First Patient in Multicenter Global Phase 2 Trial of ABP-745 for Acute Gout Flares

Atom Therapeutics, a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, announced today it has enrolled the first patient in a multi-country Phase 2 trial...

September 12, 2025
Business Wire
Artificial Intelligence, Healthcare, News

Intrepid Phoenix Ventures Announces Collaboration with the Indiana University School of Social Work on a Department of Defense SBIR Phase I Grant

Intrepid Phoenix Ventures, Inc., an Indiana-based corporation headquartered in Mishawaka, is pleased to announce it has been awarded a Department of Defense (DoD) SBIR Phase I Grant through the...

September 11, 2025
Business Wire
Artificial Intelligence, Healthcare, News

Masimo Announces Expansion of Strategic Partnership with Philips

Masimo (NASDAQ: MASI) today announced a multi-year renewal and expansion of its strategic partnership with Royal Philips (NYSE: PHG, AEX: PHIA). Building on over two decades of collaboration, this significant partnership expansion...

September 11, 2025
Business Wire
Artificial Intelligence, Data Management Platform, Healthcare, News, Security

DNAnexus and Oracle Join Forces to Deliver Genomic Insights at the Point of Care

DNAnexus, Inc., global provider of the leading enterprise platform for precision health data, today announced its intention to bring precision medicine capabilities to select Oracle Health clinical applications. Incorporating genomic data...

September 11, 2025
PRNewswire
Biotechnology, Healthcare, News

Kazia Therapeutics Reports Complete Ex Vivo Disruption of Large Circulating Tumor Cell Clusters in Stage IV HER2-Positive Breast Cancer with Paxalisib Monotherapy

Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced new findings from a collaborative research program led by Professor Sudha Rao at QIMR Berghofer. In this ex vivo study,...